US20180153847A1 - Treprostinil prodrugs - Google Patents
Treprostinil prodrugs Download PDFInfo
- Publication number
- US20180153847A1 US20180153847A1 US15/716,007 US201715716007A US2018153847A1 US 20180153847 A1 US20180153847 A1 US 20180153847A1 US 201715716007 A US201715716007 A US 201715716007A US 2018153847 A1 US2018153847 A1 US 2018153847A1
- Authority
- US
- United States
- Prior art keywords
- treprostinil
- prodrug
- group
- canceled
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 CCCCC[C@@](CC[C@@]([C@](*)C1)[C@@](C2)[C@@]1Cc1c2cccc1OCC(OCc1ccccc1)=O)O Chemical compound CCCCC[C@@](CC[C@@]([C@](*)C1)[C@@](C2)[C@@]1Cc1c2cccc1OCC(OCc1ccccc1)=O)O 0.000 description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N CC(C)=O Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- XJPGXTHTQZLUDL-HUTLKBDOSA-N [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](O)C2 XJPGXTHTQZLUDL-HUTLKBDOSA-N 0.000 description 4
- KZIXCASCFWOMCL-UHFFFAOYSA-N CC(=O)[Y] Chemical compound CC(=O)[Y] KZIXCASCFWOMCL-UHFFFAOYSA-N 0.000 description 3
- UURWMUKOSVZSAN-NRVWXBNFSA-N [H][C@@]12CC3=C(OCC(=O)NCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](C)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@H](C(=O)O)C(C)C)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](C)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@H](C(=O)O)C(C)C)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 UURWMUKOSVZSAN-NRVWXBNFSA-N 0.000 description 3
- SFQALBHZYXANJR-QFUMKASJSA-N [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)NC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)NC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 SFQALBHZYXANJR-QFUMKASJSA-N 0.000 description 3
- XGAKFNILHOSTDZ-QXPYLXRVSA-N C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 Chemical compound C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 XGAKFNILHOSTDZ-QXPYLXRVSA-N 0.000 description 2
- AUCJWKLDIVSLBO-MSIOFHLASA-N C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 Chemical compound C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 AUCJWKLDIVSLBO-MSIOFHLASA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N CC(=O)N(C)C Chemical compound CC(=O)N(C)C FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- YIIMEMSDCNDGTB-UHFFFAOYSA-N CN(C)C(=O)Cl Chemical compound CN(C)C(=O)Cl YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N COC(=O)Cl Chemical compound COC(=O)Cl XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N COC(C)=O Chemical compound COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- JVBPQHDRDDUMOX-UHFFFAOYSA-N [H]C(=O)C1=CC=CC(P)=C1CC=C Chemical compound [H]C(=O)C1=CC=CC(P)=C1CC=C JVBPQHDRDDUMOX-UHFFFAOYSA-N 0.000 description 2
- TYMCHNHMYMZXDB-NJHFACHNSA-N [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2 TYMCHNHMYMZXDB-NJHFACHNSA-N 0.000 description 2
- UZLGXXULOYXOMM-SNVBAGLBSA-N C#CCC[C@@H](P)CCCCC Chemical compound C#CCC[C@@H](P)CCCCC UZLGXXULOYXOMM-SNVBAGLBSA-N 0.000 description 1
- SEIYBBWHPKMBDW-DVKZKHMMSA-N C.C.C.C.C.C.COC(=O)Cl.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2 Chemical compound C.C.C.C.C.C.COC(=O)Cl.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2 SEIYBBWHPKMBDW-DVKZKHMMSA-N 0.000 description 1
- QOIIXVLRMFRNNL-SGAQPHCGSA-N C.C.C.C.C.COC(=O)Cl.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 Chemical compound C.C.C.C.C.COC(=O)Cl.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 QOIIXVLRMFRNNL-SGAQPHCGSA-N 0.000 description 1
- FWEGEJMLTLVFKK-PQRLECRQSA-N C.C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound C.C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 FWEGEJMLTLVFKK-PQRLECRQSA-N 0.000 description 1
- DOMSNGVXMRTGOG-ZPTZRHKDSA-N C.C.C.[3H-15][U].[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OC)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound C.C.C.[3H-15][U].[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OC)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 DOMSNGVXMRTGOG-ZPTZRHKDSA-N 0.000 description 1
- AUYITBZKGZJNNA-GZFMYKTGSA-N C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 Chemical compound C.C.C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 AUYITBZKGZJNNA-GZFMYKTGSA-N 0.000 description 1
- JZCRTWCUUSZQLT-MCVFPVQVSA-N C.C.COC(=O)Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2 Chemical compound C.C.COC(=O)Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2 JZCRTWCUUSZQLT-MCVFPVQVSA-N 0.000 description 1
- NIRHXYROAUKFAI-HMVVGCIYSA-N C.C.COC(=O)Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2 Chemical compound C.C.COC(=O)Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2 NIRHXYROAUKFAI-HMVVGCIYSA-N 0.000 description 1
- SNUIGPFGTQNTHG-PDOKIGCRSA-N C.C.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 Chemical compound C.C.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2 SNUIGPFGTQNTHG-PDOKIGCRSA-N 0.000 description 1
- RQSDYNXXCMWJSM-HNPUSPJQSA-N C.C.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 Chemical compound C.C.NCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 RQSDYNXXCMWJSM-HNPUSPJQSA-N 0.000 description 1
- ZFYXRYCZJUFTEF-VVOYICTDSA-N C.C.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound C.C.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 ZFYXRYCZJUFTEF-VVOYICTDSA-N 0.000 description 1
- NBCHSTRAMKKCCH-XEERIIOPSA-N C.C.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2 Chemical compound C.C.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2 NBCHSTRAMKKCCH-XEERIIOPSA-N 0.000 description 1
- LFQBZPXSQXFRIL-DSCZCPNPSA-N C.C1CCOC1.CCOC(C)=O.NN=Cl.O=C(Cl)OC1=CC=C([N+](=O)[O-])C=C1.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)O)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]NC.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC1=CC=C([N+](=O)[O-])C=C1)[C@H](C)C2 Chemical compound C.C1CCOC1.CCOC(C)=O.NN=Cl.O=C(Cl)OC1=CC=C([N+](=O)[O-])C=C1.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)O)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]NC.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC1=CC=C([N+](=O)[O-])C=C1)[C@H](C)C2 LFQBZPXSQXFRIL-DSCZCPNPSA-N 0.000 description 1
- KVJKGGZRYWVQCP-VVOYICTDSA-N C.CCOC(C)=O.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)O)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H] Chemical compound C.CCOC(C)=O.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)O)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H] KVJKGGZRYWVQCP-VVOYICTDSA-N 0.000 description 1
- IAMDYCXSLJTELW-QWFAFKLTSA-N C.CCOC(C)=O.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2 Chemical compound C.CCOC(C)=O.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2 IAMDYCXSLJTELW-QWFAFKLTSA-N 0.000 description 1
- HHHMCNRLJTVFMZ-CETQLUFQSA-N C.CCOC(C)=O.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2 Chemical compound C.CCOC(C)=O.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2 HHHMCNRLJTVFMZ-CETQLUFQSA-N 0.000 description 1
- MSAQLNFMGPNWEC-ABOUFBCTSA-N C.[3H-15][U].[H][C@@]12Cc3c(cccc3OCC(=O)NCN(O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound C.[3H-15][U].[H][C@@]12Cc3c(cccc3OCC(=O)NCN(O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12Cc3c(cccc3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 MSAQLNFMGPNWEC-ABOUFBCTSA-N 0.000 description 1
- ZYPGFIFOZISWML-KNTFONOJSA-N C1CCOC1.CS(N)(=O)=O.[2H]CI.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OC(=O)N3C=CN=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 Chemical compound C1CCOC1.CS(N)(=O)=O.[2H]CI.[H][C@@]12CC3=C(C=CC=C3OCC(=O)NS(C)(=O)=O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OC(=O)N3C=CN=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 ZYPGFIFOZISWML-KNTFONOJSA-N 0.000 description 1
- GCZQJXLJJDFACI-AEZNQQJFSA-N C1CCOC1.O=C(Cl)OC1=CC=C([N+](=O)[O-])C=C1.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]NC.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC1=CC=C([N+](=O)[O-])C=C1)[C@H](C)C2 Chemical compound C1CCOC1.O=C(Cl)OC1=CC=C([N+](=O)[O-])C=C1.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]NC.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC1=CC=C([N+](=O)[O-])C=C1)[C@H](C)C2 GCZQJXLJJDFACI-AEZNQQJFSA-N 0.000 description 1
- NIUZXKPBKQQCMH-LPHOPBHVSA-N C=CCC1=C(P)C=CC=C1[C@@H](O)C#CCC[C@H](CCCCC)OP Chemical compound C=CCC1=C(P)C=CC=C1[C@@H](O)C#CCC[C@H](CCCCC)OP NIUZXKPBKQQCMH-LPHOPBHVSA-N 0.000 description 1
- QZSPAZVWXVZLCX-JQJUMTEASA-N CC(=O)C[C@H](N)C(=O)OCC1=CC=CC=C1.CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CC(=O)O)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CC(=O)OCC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound CC(=O)C[C@H](N)C(=O)OCC1=CC=CC=C1.CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CC(=O)O)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CC(=O)OCC1=CC=CC=C1)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 QZSPAZVWXVZLCX-JQJUMTEASA-N 0.000 description 1
- FSWJEERMPZVJMY-YRPPFFDISA-N CC(C)(C)[Si](C)(C)OS(=O)(=O)C(F)(F)F.ClCCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 Chemical compound CC(C)(C)[Si](C)(C)OS(=O)(=O)C(F)(F)F.ClCCl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 FSWJEERMPZVJMY-YRPPFFDISA-N 0.000 description 1
- GOIDCYLOJFSCLQ-DAWOLGGHSA-N CC(C)[C@H](N)C(=O)OCC1=CC=CC=C1.CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C(=O)O)C(C)C.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C(=O)OCC1=CC=CC=C1)C(C)C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound CC(C)[C@H](N)C(=O)OCC1=CC=CC=C1.CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C(=O)O)C(C)C.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C(=O)OCC1=CC=CC=C1)C(C)C.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 GOIDCYLOJFSCLQ-DAWOLGGHSA-N 0.000 description 1
- OMRDBFGDBBMHEQ-QPLOZBTESA-N CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.C[C@H](N)C(=O)OCC1=CC=CC=C1.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound CC1=CC=C(S(=O)(=O)O)C=C1.CCOC(C)=O.C[C@H](N)C(=O)OCC1=CC=CC=C1.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(C)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 OMRDBFGDBBMHEQ-QPLOZBTESA-N 0.000 description 1
- QRQDYMYZZRMCAI-UHFFFAOYSA-N CCC1=CC=C(C)C=C1.CCC1=CCC2=CC=CC=C12.CCC1=CCC=N1 Chemical compound CCC1=CC=C(C)C=C1.CCC1=CCC2=CC=CC=C12.CCC1=CCC=N1 QRQDYMYZZRMCAI-UHFFFAOYSA-N 0.000 description 1
- ZHYMTVDNQHMHFP-SXFAUFNYSA-N CCCCC[C@@H](CC[C@@H]([C@@H](C1)O)[C@@H](C2)[C@H]1Cc1c2cccc1OCC(O)=O)OC(NC)=O Chemical compound CCCCC[C@@H](CC[C@@H]([C@@H](C1)O)[C@@H](C2)[C@H]1Cc1c2cccc1OCC(O)=O)OC(NC)=O ZHYMTVDNQHMHFP-SXFAUFNYSA-N 0.000 description 1
- UWUOECJVNHXBKO-DYXRGMLLSA-N CCCCC[C@@H](CC[C@@H]([C@@H](C1)O)[C@@H](Cc2ccc3)[C@H]1Cc2c3OCC(OCc1ccccc1)=O)OC(NC)=O Chemical compound CCCCC[C@@H](CC[C@@H]([C@@H](C1)O)[C@@H](Cc2ccc3)[C@H]1Cc2c3OCC(OCc1ccccc1)=O)OC(NC)=O UWUOECJVNHXBKO-DYXRGMLLSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N CCOC(=O)CBr Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- JWIIXKOBFCSTTD-CFEHWCJKSA-N CCOC(C)=O.C[Pd].[HH].[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 Chemical compound CCOC(C)=O.C[Pd].[HH].[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)C2 JWIIXKOBFCSTTD-CFEHWCJKSA-N 0.000 description 1
- FVAVEHBENVWIJR-IYTHDPPVSA-N CCOC(C)=O.N[C@@H](CO)C(=O)OCC1=CC=CC=C1.O=S(=O)(O)C1=CC=CC=C1.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CO)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CO)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound CCOC(C)=O.N[C@@H](CO)C(=O)OCC1=CC=CC=C1.O=S(=O)(O)C1=CC=CC=C1.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CO)C(=O)O.[H]N(C(=O)COC1=CC=CC2=C1C[C@@]1([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])C2)C(CO)C(=O)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 FVAVEHBENVWIJR-IYTHDPPVSA-N 0.000 description 1
- BKFYXZAGINBPCB-NQLGOFCKSA-N NN=Cl.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H] Chemical compound NN=Cl.[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](C)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H].[H]N(C)C(=O)O[C@@H](CCCCC)CC[C@H]1[C@H](O)C[C@]2([H])CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]12[H] BKFYXZAGINBPCB-NQLGOFCKSA-N 0.000 description 1
- RRLVZPOXKUHMDF-LJWMXFBRSA-N NN=Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2 Chemical compound NN=Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2 RRLVZPOXKUHMDF-LJWMXFBRSA-N 0.000 description 1
- CBQGKWDCDCWGHL-WPKSQZSCSA-N NN=Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2 Chemical compound NN=Cl.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2 CBQGKWDCDCWGHL-WPKSQZSCSA-N 0.000 description 1
- JHVLLYQQQYIWKX-UHFFFAOYSA-N O=C(CBr)OCC1=CC=CC=C1 Chemical compound O=C(CBr)OCC1=CC=CC=C1 JHVLLYQQQYIWKX-UHFFFAOYSA-N 0.000 description 1
- CEJZFIUQVUOLMH-CLOQKIJRSA-N O=C(CBr)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound O=C(CBr)OCC1=CC=CC=C1.[H][C@@]12CC3=C(C=CC=C3O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 CEJZFIUQVUOLMH-CLOQKIJRSA-N 0.000 description 1
- GGICHNFZKNHWEG-KOVXWOGCSA-N [H][C@@]12CC3=C(C)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](OPP)C2 Chemical compound [H][C@@]12CC3=C(C)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](OPP)C2 GGICHNFZKNHWEG-KOVXWOGCSA-N 0.000 description 1
- GUCMISJVUWBXES-IDKZSHENSA-N [H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)C(OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)C(OC(=O)OC)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)O)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 GUCMISJVUWBXES-IDKZSHENSA-N 0.000 description 1
- XJGQAAFCWMYAAK-RQWUUVHASA-N [H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)N(C)C)C2 Chemical compound [H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](C)CCCCC)[C@H](OC(=O)N(C)C)C2 XJGQAAFCWMYAAK-RQWUUVHASA-N 0.000 description 1
- XXARSLUQNAHXQD-DEMPXORFSA-N [H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](C)C2 Chemical compound [H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](C)C2.[H][C@@]12CC3=C(C=CC=C3OCC(=O)OCC3=CC=CC=C3)C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](C)C2 XXARSLUQNAHXQD-DEMPXORFSA-N 0.000 description 1
- ZISWVWIPYONJHV-OBSCOMINSA-N [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](O)C2 ZISWVWIPYONJHV-OBSCOMINSA-N 0.000 description 1
- HYICSLAATXWTJI-HUTLKBDOSA-N [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](OPP)C2 Chemical compound [H][C@@]12CC3=C(O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](OPP)C2 HYICSLAATXWTJI-HUTLKBDOSA-N 0.000 description 1
- JFWHIMOCPLHMEC-CEWIYYKHSA-N [H][C@@]12CC3=C(OCC(=O)NCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)NC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP(=O)(O)O)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)NC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP(=O)(O)O)[C@H](O)C2 JFWHIMOCPLHMEC-CEWIYYKHSA-N 0.000 description 1
- FMNVNBIDLXGSLY-QVPBSXMQSA-N [H][C@@]12CC3=C(OCC(=O)NCC(=O)OCC4=CC=CC=C4)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)O)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NCC(=O)OCC4=CC=CC=C4)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)O)[C@H](O)C2 FMNVNBIDLXGSLY-QVPBSXMQSA-N 0.000 description 1
- VYIWHWUMPPCPGR-SGHIAJGHSA-N [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OP(=O)(O)O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP(=O)(O)O)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OP(=O)(O)O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC)[C@H](OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP(=O)(O)O)[C@H](O)C2 VYIWHWUMPPCPGR-SGHIAJGHSA-N 0.000 description 1
- LSZNUSLNBSWUHZ-BEAXMNRUSA-N [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)NS(C)(=O)=O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 LSZNUSLNBSWUHZ-BEAXMNRUSA-N 0.000 description 1
- CTVDUDVGBZQQMA-ZUBCITKWSA-N [H][C@@]12CC3=C(OCC(=O)N[C@@H](C)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@H](C(=O)O)C(C)C)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)N[C@@H](C)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CC(=O)O)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@@H](CO)C(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)N[C@H](C(=O)O)C(C)C)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 CTVDUDVGBZQQMA-ZUBCITKWSA-N 0.000 description 1
- PAJMKGZZBBTTOY-ZFORQUDYSA-N [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 PAJMKGZZBBTTOY-ZFORQUDYSA-N 0.000 description 1
- OLVOMADCJOUYFS-LTZFHKJSSA-N [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OP(=O)(O)O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)N(C)C)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OC(=O)OC)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OP(=O)(O)O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)N(C)C)[C@H](O)C2.[H][C@@]12CC3=C(OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OC(=O)OC)[C@H](O)C2 OLVOMADCJOUYFS-LTZFHKJSSA-N 0.000 description 1
- AJANOCCMLVNRPM-SXFAUFNYSA-N [H][C@@]12CC3=C(OCC(=O)OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)OCC(=O)O)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 AJANOCCMLVNRPM-SXFAUFNYSA-N 0.000 description 1
- ZEMHIOLRSWXVJJ-KSSXRGRSSA-N [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OPP)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](OPP)C2 ZEMHIOLRSWXVJJ-KSSXRGRSSA-N 0.000 description 1
- PUANAFSVGXLEQC-FUAJKEFHSA-N [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](O)C2 PUANAFSVGXLEQC-FUAJKEFHSA-N 0.000 description 1
- YTNHUIQYWCFVER-ZKRAEAORSA-N [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](OPP)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](C)OP)[C@H](OPP)C2 YTNHUIQYWCFVER-ZKRAEAORSA-N 0.000 description 1
- XHNHINIRJHYGFL-ZFORQUDYSA-N [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](O)C2 Chemical compound [H][C@@]12CC3=C(OCC(=O)OP)C=CC=C3C[C@]1([H])[C@@H](CC[C@H](CCCCC)OP)[C@H](O)C2 XHNHINIRJHYGFL-ZFORQUDYSA-N 0.000 description 1
- RMALNMAXBVJBJV-SXFAUFNYSA-N [H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 Chemical compound [H][C@@]12Cc3c(cccc3OCC(=O)NCC(=O)O)C[C@]1([H])[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C2 RMALNMAXBVJBJV-SXFAUFNYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/716,007 US20180153847A1 (en) | 2016-09-26 | 2017-09-26 | Treprostinil prodrugs |
US17/140,705 US11672775B2 (en) | 2016-09-26 | 2021-01-04 | Treprostinil prodrugs |
US18/141,170 US20230255922A1 (en) | 2016-09-26 | 2023-04-28 | Treprostinil prodrugs |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662399737P | 2016-09-26 | 2016-09-26 | |
US15/716,007 US20180153847A1 (en) | 2016-09-26 | 2017-09-26 | Treprostinil prodrugs |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/140,705 Continuation US11672775B2 (en) | 2016-09-26 | 2021-01-04 | Treprostinil prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180153847A1 true US20180153847A1 (en) | 2018-06-07 |
Family
ID=60120132
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/716,007 Abandoned US20180153847A1 (en) | 2016-09-26 | 2017-09-26 | Treprostinil prodrugs |
US17/140,705 Active 2038-02-20 US11672775B2 (en) | 2016-09-26 | 2021-01-04 | Treprostinil prodrugs |
US18/141,170 Pending US20230255922A1 (en) | 2016-09-26 | 2023-04-28 | Treprostinil prodrugs |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/140,705 Active 2038-02-20 US11672775B2 (en) | 2016-09-26 | 2021-01-04 | Treprostinil prodrugs |
US18/141,170 Pending US20230255922A1 (en) | 2016-09-26 | 2023-04-28 | Treprostinil prodrugs |
Country Status (9)
Country | Link |
---|---|
US (3) | US20180153847A1 (fr) |
EP (1) | EP3515430A1 (fr) |
JP (2) | JP7220650B2 (fr) |
KR (1) | KR102541885B1 (fr) |
CN (1) | CN110678174A (fr) |
AU (1) | AU2017330099B2 (fr) |
CA (1) | CA3038276A1 (fr) |
IL (1) | IL265588A (fr) |
WO (1) | WO2018058124A1 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020223237A1 (fr) * | 2019-04-29 | 2020-11-05 | Insmed Incorporated | Compositions de poudre sèche de promédicaments de tréprostinil et méthodes d'utilisation de celles-ci |
WO2021041320A1 (fr) | 2019-08-23 | 2021-03-04 | United Therapeutics Corporation | Promédicaments de tréprostinil |
US10995055B2 (en) | 2013-10-25 | 2021-05-04 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
US11148997B2 (en) | 2014-11-18 | 2021-10-19 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
WO2021211916A1 (fr) | 2020-04-17 | 2021-10-21 | United Therapeutics Corporation | Tréprostinil destiné à être utilisé dans le traitement d'une pneumopathie interstitielle |
WO2022132655A1 (fr) | 2020-12-14 | 2022-06-23 | United Therapeutics Corporation | Méthodes de traitement d'une maladie à l'aide de promédicaments tréprostinil |
WO2022187352A1 (fr) | 2021-03-03 | 2022-09-09 | United Therapeutics Corporation | Composition de poudre sèche de treprostinil et son promédicament et comprenant en outre de l'(e)-3,6-bis[4-(n-carbonyl-2-propényl)amidobutyl]-2,5-dicétopipérazine (fdkp) |
WO2023154705A1 (fr) | 2022-02-08 | 2023-08-17 | United Therapeutics Corporation | Polythérapie à base de tréprostinil iloprost |
US11793780B2 (en) | 2020-06-09 | 2023-10-24 | United Therapeutics Corporation | Prodrugs of treprosiinil |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022194195A1 (fr) * | 2021-03-16 | 2022-09-22 | 江苏恒瑞医药股份有限公司 | Dérivé de tréprostinil et son utilisation |
CN116444377A (zh) * | 2022-01-07 | 2023-07-18 | 广州楷石医药有限公司 | 一种氧化氮供体型曲前列尼尔类衍生物及其药物组合物和用途 |
CN115894240A (zh) * | 2022-10-14 | 2023-04-04 | 广州楷石医药有限公司 | 曲前列尼尔的前体药物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150166503A1 (en) * | 2013-01-11 | 2015-06-18 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
GB8814438D0 (en) | 1988-06-17 | 1988-07-20 | Wellcome Found | Compounds for use in medicine |
GB9011588D0 (en) | 1990-05-24 | 1990-07-11 | Wellcome Found | Prostaglandin analogues for use in medicine |
US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
KR100638684B1 (ko) | 1997-11-14 | 2006-10-27 | 유나이티드 세러퓨틱스 코오포레이션 | 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도 |
US6521212B1 (en) | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
AU4327300A (en) | 1999-03-31 | 2000-10-16 | United Therapeutics Corporation | Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
US6700025B2 (en) | 2001-01-05 | 2004-03-02 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
US20030108512A1 (en) | 2001-12-10 | 2003-06-12 | Robert Shorr | Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer |
US6803386B2 (en) | 2002-01-16 | 2004-10-12 | United Therapeutics Corporation | Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer |
US6756117B1 (en) | 2002-12-20 | 2004-06-29 | The United States Of America As Represented By The United States Department Of Energy | Photonic polymer-blend structures and method for making |
US6950480B2 (en) | 2003-01-24 | 2005-09-27 | Texas Instruments Incorporated | Receiver having automatic burst mode I/Q gain and phase balance |
EP1628654B2 (fr) | 2003-05-22 | 2019-12-04 | United Therapeutics Corporation | Composés et procédés destinés à l'administration d'analogues de prostacycline |
US20090124697A1 (en) | 2003-12-16 | 2009-05-14 | United Therapeutics Corporation | Inhalation formulations of treprostinil |
CN101647792B (zh) | 2003-12-16 | 2012-11-28 | 联合治疗公司 | 曲前列环素在制备治疗和预防缺血性损害的药物中的用途 |
CN1917883B (zh) | 2003-12-16 | 2011-05-11 | 联合治疗公司 | 曲前列环素在制备改善肾功能的药物中的用途 |
US7879909B2 (en) | 2004-04-12 | 2011-02-01 | United Therapeutics Corporation | Use of Treprostinil to treat neuropathic diabetic foot ulcers |
US8747897B2 (en) | 2006-04-27 | 2014-06-10 | Supernus Pharmaceuticals, Inc. | Osmotic drug delivery system |
KR101390579B1 (ko) | 2006-05-15 | 2014-05-19 | 유나이티드 세러퓨틱스 코오포레이션 | 정량 흡입기를 사용한 트레프로스티닐 투여 |
US20090036465A1 (en) | 2006-10-18 | 2009-02-05 | United Therapeutics Corporation | Combination therapy for pulmonary arterial hypertension |
CA2678258A1 (fr) | 2007-02-09 | 2008-08-14 | United Therapeutics Corporation | Traitement au treprostinil d'une maladie pulmonaire interstitielle et de l'asthme |
JP2010538092A (ja) | 2007-09-07 | 2010-12-09 | ユナイテッド セラピューティクス コーポレーション | グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法 |
EP2252570B1 (fr) | 2007-12-17 | 2017-04-05 | United Therapeutics Corporation | Procede ameliore de preparation de treprostinil, l'ingredient actif dans le remodulin ® |
JP6219016B2 (ja) | 2008-05-08 | 2017-10-25 | ユナイテッド セラピューティクス コーポレーション | トレプロスチニル一水和物 |
WO2009152160A1 (fr) * | 2008-06-10 | 2009-12-17 | Gilead Sciences, Inc. | Promédicaments inhalés à base de carbaprostacyclines et de prostacyclines destinés au traitement de l'hypertension artérielle pulmonaire |
WO2010129757A1 (fr) | 2009-05-07 | 2010-11-11 | United Therapeutics Corporation | Compositions solides à base d'analogues de prostacycline |
BR112012002578B8 (pt) | 2009-08-07 | 2021-05-25 | Scipharm Sarl | usos de treprostinil ou de um derivado ou de um sal farmaceuticamente aceitável do mesmo para tratamento da fibrose cística |
ES2611187T3 (es) | 2010-03-15 | 2017-05-05 | United Therapeutics Corporation | Tratamiento para hipertensión pulmonar |
JP6046034B2 (ja) | 2010-06-03 | 2016-12-14 | ユナイテッド セラピューティクス コーポレイション | トレプロスチニルの製造 |
CA2710725C (fr) | 2010-07-22 | 2017-08-01 | Alphora Research Inc. | Aldehydes proteges pour une utilisation comme intermediaires pour des syntheses chimiques, et procedes pour leur preparation |
CA2710726C (fr) | 2010-07-22 | 2016-02-23 | Alphora Research Inc. | Synthese de treprostinil et intermediaires utiles pour celle-ci |
CA2726599C (fr) | 2010-12-30 | 2017-07-25 | Alphora Research Inc. | Procede de preparation de sel a partir de treprostinil |
US8461393B2 (en) | 2011-03-02 | 2013-06-11 | United Therapeutics Corporation | Synthesis of intermediate for treprostinil production |
US9388154B2 (en) | 2011-09-12 | 2016-07-12 | Lund Biotechnology PBC | Process for preparing synthetic prostacyclins |
CN103193626B (zh) | 2012-01-10 | 2016-05-11 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
CN103193627B (zh) | 2012-01-10 | 2016-04-20 | 上海天伟生物制药有限公司 | 一种前列腺素类似物的晶型及其制备方法和用途 |
US9387214B2 (en) | 2012-01-13 | 2016-07-12 | United Therapeutics Corporation | Method of identifying therapies for pulmonary hypertension |
SI2674413T1 (sl) | 2012-06-15 | 2017-10-30 | Scipharm Sarl | Postopek za pripravo treprostinila in derivatov le-tega |
CA2890219A1 (fr) | 2012-11-30 | 2014-06-05 | Insmed Incorporated | Compositions de prostacycline et leurs procedes d'utilisation |
EP3398931B1 (fr) | 2012-12-07 | 2020-04-08 | Cayman Chemical Company, Incorporated | Procédés de synthèse d'un analogue de la prostacycline |
EP3712142B1 (fr) | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Promédicaments de tréprostinil |
CA3125504C (fr) | 2013-03-14 | 2023-10-24 | United Therapeutics Corporation | Formes solides de treprostinil |
US20140275616A1 (en) | 2013-03-15 | 2014-09-18 | United Therapeutics Corporation | Salts of treprostinil |
WO2014179295A1 (fr) | 2013-04-30 | 2014-11-06 | United Therapeutics Corporation | Formulations pharmaceutiques à libération contrôlée |
WO2015061720A2 (fr) | 2013-10-25 | 2015-04-30 | Insmed Incorporated | Composés de prostacycline, compositions en contenant et leurs procédés d'utilisation |
CN103663895B (zh) | 2013-12-03 | 2015-05-13 | 南京德磊科技有限公司 | 污泥处理系统及其方法 |
TWI685348B (zh) | 2014-05-08 | 2020-02-21 | 美國禮來大藥廠 | 速效胰島素組合物 |
EP3169660A1 (fr) | 2014-07-16 | 2017-05-24 | Corsair Pharma, Inc. | Composés de dérivés de tréprostinil et leurs procédés d'utilisation |
US20160045470A1 (en) | 2014-08-12 | 2016-02-18 | Dr. Reddy's Laboratories Limited | Amorphous solid dispersion of treprostinil diethanolamine |
WO2016038532A1 (fr) | 2014-09-09 | 2016-03-17 | Mylan Laboratories Limited | Tréprostinil diéthanolamine amorphe |
HU231186B1 (hu) | 2014-10-08 | 2021-06-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Új eljárás treprostinil és sói előállítására |
EP3209415B1 (fr) | 2014-10-20 | 2020-02-19 | United Therapeutics Corporation | Synthèse d'intermédiaires pour la production de dérivés de prostacycline |
JP6866043B2 (ja) * | 2014-11-18 | 2021-04-28 | インスメッド インコーポレイテッド | トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法 |
TWI540121B (zh) | 2014-12-01 | 2016-07-01 | 臺灣永光化學工業股份有限公司 | 曲前列環素二乙醇胺之合成方法及新穎中間體 |
WO2016105538A1 (fr) | 2014-12-23 | 2016-06-30 | Sandia Corporation Sandia National Laboratories | Ajustement du ph d'une solution de prétraitement à l'aide de dioxyde de carbone utile pour intégrer une saccharification et une fermentation |
US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
US9394227B1 (en) * | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
-
2017
- 2017-09-26 WO PCT/US2017/053503 patent/WO2018058124A1/fr active Application Filing
- 2017-09-26 KR KR1020197012107A patent/KR102541885B1/ko active IP Right Grant
- 2017-09-26 JP JP2019516117A patent/JP7220650B2/ja active Active
- 2017-09-26 AU AU2017330099A patent/AU2017330099B2/en active Active
- 2017-09-26 US US15/716,007 patent/US20180153847A1/en not_active Abandoned
- 2017-09-26 EP EP17785072.4A patent/EP3515430A1/fr active Pending
- 2017-09-26 CN CN201780073235.5A patent/CN110678174A/zh active Pending
- 2017-09-26 CA CA3038276A patent/CA3038276A1/fr active Pending
-
2019
- 2019-03-25 IL IL265588A patent/IL265588A/en unknown
-
2021
- 2021-01-04 US US17/140,705 patent/US11672775B2/en active Active
-
2022
- 2022-09-16 JP JP2022147493A patent/JP2022188082A/ja active Pending
-
2023
- 2023-04-28 US US18/141,170 patent/US20230255922A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150166503A1 (en) * | 2013-01-11 | 2015-06-18 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11795135B2 (en) | 2013-10-25 | 2023-10-24 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
US10995055B2 (en) | 2013-10-25 | 2021-05-04 | Insmed Incorporated | Prostacyclin compounds, compositions and methods of use thereof |
US11148997B2 (en) | 2014-11-18 | 2021-10-19 | Insmed Incorporated | Methods of manufacturing treprostinil and treprostinil derivative prodrugs |
US11458098B2 (en) | 2019-04-29 | 2022-10-04 | Insmed Incorporated | Dry powder compositions of treprostinil prodrugs and methods of use thereof |
WO2020223237A1 (fr) * | 2019-04-29 | 2020-11-05 | Insmed Incorporated | Compositions de poudre sèche de promédicaments de tréprostinil et méthodes d'utilisation de celles-ci |
US11759425B2 (en) | 2019-04-29 | 2023-09-19 | Insmed Incorporated | Dry powder compositions of treprostinil prodrugs and methods of use thereof |
US11634443B2 (en) | 2019-08-23 | 2023-04-25 | United Therapeutics Corporation | Treprostinil prodrugs |
WO2021041320A1 (fr) | 2019-08-23 | 2021-03-04 | United Therapeutics Corporation | Promédicaments de tréprostinil |
WO2021211916A1 (fr) | 2020-04-17 | 2021-10-21 | United Therapeutics Corporation | Tréprostinil destiné à être utilisé dans le traitement d'une pneumopathie interstitielle |
US20210330621A1 (en) | 2020-04-17 | 2021-10-28 | United Therapeutics Corporation | Treatment for interstitial lung disease |
US11826327B2 (en) | 2020-04-17 | 2023-11-28 | United Therapeutics Corporation | Treatment for interstitial lung disease |
US11793780B2 (en) | 2020-06-09 | 2023-10-24 | United Therapeutics Corporation | Prodrugs of treprosiinil |
WO2022132655A1 (fr) | 2020-12-14 | 2022-06-23 | United Therapeutics Corporation | Méthodes de traitement d'une maladie à l'aide de promédicaments tréprostinil |
US11826328B2 (en) | 2020-12-14 | 2023-11-28 | United Therapeutics Corporation | Stable treprostinil prodrugs |
WO2022187352A1 (fr) | 2021-03-03 | 2022-09-09 | United Therapeutics Corporation | Composition de poudre sèche de treprostinil et son promédicament et comprenant en outre de l'(e)-3,6-bis[4-(n-carbonyl-2-propényl)amidobutyl]-2,5-dicétopipérazine (fdkp) |
WO2023154705A1 (fr) | 2022-02-08 | 2023-08-17 | United Therapeutics Corporation | Polythérapie à base de tréprostinil iloprost |
Also Published As
Publication number | Publication date |
---|---|
AU2017330099A1 (en) | 2019-04-18 |
CA3038276A1 (fr) | 2018-03-29 |
KR20190092372A (ko) | 2019-08-07 |
JP7220650B2 (ja) | 2023-02-10 |
JP2019536741A (ja) | 2019-12-19 |
KR102541885B1 (ko) | 2023-06-12 |
IL265588A (en) | 2019-05-30 |
WO2018058124A1 (fr) | 2018-03-29 |
AU2017330099B2 (en) | 2023-08-10 |
US20230255922A1 (en) | 2023-08-17 |
JP2022188082A (ja) | 2022-12-20 |
US11672775B2 (en) | 2023-06-13 |
US20210121433A1 (en) | 2021-04-29 |
CN110678174A (zh) | 2020-01-10 |
EP3515430A1 (fr) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11672775B2 (en) | Treprostinil prodrugs | |
BE1023340B1 (fr) | Composes | |
JP2020196742A (ja) | 胃腸炎症性腸疾患の処置のための、jak阻害剤化合物のプロドラッグ | |
EP2344447B1 (fr) | Conjugués gaba et procédés d'utilisation de ceux-ci | |
US7160890B2 (en) | Compounds specific to adenosine A3 receptor and uses thereof | |
TW201943712A (zh) | 一種多功能化合物、其製備方法及其在醫藥上的應用 | |
EP3317287B1 (fr) | Inhibiteurs d'indoléamine 2,3-dioxygénase | |
WO2003048120A2 (fr) | Composes specifiques des recepteurs a1 et a3 de l'adenosine et leurs utilisations | |
US11634443B2 (en) | Treprostinil prodrugs | |
WO2007102888A2 (fr) | Procédés de traitement du cancer utilisant la doxazolidine et des promédicaments de celle-ci | |
CN110092779B (zh) | 一种取代的苯基化合物及其应用 | |
KR101264934B1 (ko) | 아미도메틸-치환1-(카르복시알킬)-시클로펜틸카보닐아미노-벤자제핀-n-아세트산 유도체, 그것의 제조를 위한 공정 및 중간체 생성물및 이들 화합물을 포함하는 의약품 | |
EP1353910B1 (fr) | Compose lactame | |
US9187492B2 (en) | Pyripyropene derivative having ACAT2 inhibiting activity and stable to metabolizing enzymes | |
EP1937248B1 (fr) | Amides d'acide alcanoique substitues par des o-heterocycles satures | |
CN109096219B (zh) | 一种新型抗pd-l1化合物、其应用及含其的组合物 | |
US9879020B2 (en) | GABAA agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma | |
JP4779650B2 (ja) | 高活性型リゾホスファチジン酸およびそれを用いたスクリーニング方法 | |
KR20010071197A (ko) | sPLA2 억제제 에스테르 | |
EP2738168B1 (fr) | Dérivé d'amine substitué par un n-hétérocycle | |
US20050119247A1 (en) | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them | |
US20230285598A1 (en) | Sulfoxonium ylide derivatives as probes for cysteine protease | |
CN114642739A (zh) | 一种靶向b7-h3的抗体药物偶联物、其制备方法及应用 | |
EP1947091A1 (fr) | Dérivés de pyrimidyl nitrile comme inhibiteurs de la cystéine protéase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNITED THERAPEUTICS CORPORATION, MARYLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PHARES, KEN;BATRA, HITESH;GUO, LIANG;AND OTHERS;SIGNING DATES FROM 20170928 TO 20170929;REEL/FRAME:043769/0186 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |